Activella Tablet, Film Coated
Product Images NDC 60846-232

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Activella (NDC 60846-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Activella Amneal Mfr Hd Ld 1

Chemical structure of estradiol, one of the active ingredients in Activella (estradiol/norethindrone acetate). The diagram shows the molecular framework including hydroxyl groups characteristic of estradiol.*

FDA Label Image

Activella Amneal Mfr Hd Ld 10

Activella (estradiol/norethindrone acetate) 1 mg/0.5 mg film-coated tablets blister card. The card is organized with four weekly rows labeled 1 to 4, each displaying seven circular tablet slots for days Sunday through Saturday. The label includes the Amneal Pharmaceuticals LLC logo and an NDC number 60846-232-01, indicating prescription drug use.*

FDA Label Image

Activella Amneal Mfr Hd Ld 11

Activella 1 mg/0.5 mg (estradiol/norethindrone acetate) tablets packaging label. Oral film-coated tablets supplied in a blister pack containing 28 tablets. Labeler is Amneal Pharmaceuticals LLC. The packaging includes lot number and expiration date area marked for printing.*

FDA Label Image

Activella Amneal Mfr Hd Ld 12

Packaging label for Activella (estradiol/norethindrone acetate) tablets by Amneal Pharmaceuticals LLC shows the 1 mg/0.5 mg strength in a film-coated oral tablet form. The label indicates a package containing 28 white tablets in one blister pack and includes storage instructions and barcode details.*

FDA Label Image

Activella Amneal Mfr Hd Ld 13

Packaging label of Activella (estradiol/norethindrone acetate) tablets, 1 mg/0.5 mg film-coated oral tablets by Amneal Pharmaceuticals LLC. The label displays a weekly pill organizer with days of the week and four rows labeled 1 to 4 for a 28-tablet pack. The NDC 60846-232-01 is shown with barcodes and Amneal logo.*

FDA Label Image

Activella Amneal Mfr Hd Ld 14

Packaging label for Activella 0.5 mg/0.1 mg tablets containing estradiol and norethindrone acetate. The label indicates a prescription drug in film-coated tablet form, supplied by Amneal Pharmaceuticals LLC. The box contains 1 blister pack with 28 white tablets, each tablet containing 0.5 mg estradiol and 0.1 mg norethindrone acetate.*

FDA Label Image

Activella Amneal Mfr Hd Ld 15

Activella 0.5 mg/0.1 mg tablets packaging label for oral use, containing 28 white film-coated tablets. Each tablet contains 0.5 mg estradiol and 0.1 mg norethindrone acetate. The label displays the Amneal Pharmaceuticals LLC logo and barcode, and storage instructions to keep the product in a dry place between 20° to 25°C (68° to 77°F), with permitted excursions between 15° to 30°C (59° to 86°F).*

FDA Label Image

Activella Amneal Mfr Hd Ld 16

Activella (estradiol/norethindrone acetate) tablets 0.5 mg/0.1 mg film-coated oral tablets, packaged in a blister card labeled with days of the week and numbered doses for a 28-day cycle. The label includes the Amneal Pharmaceuticals LLC logo, the NDC 60846-231-01, and instructions to "start here and follow the arrows."*

FDA Label Image

Activella Amneal Mfr Hd Ld 2

Chemical structure of estradiol, one of the active ingredients in Activella (estradiol/norethindrone acetate). The diagram shows the molecular structure with rings, hydroxyl group, and acetate functional group as typical of estradiol acetate.*

FDA Label Image

Activella Amneal Mfr Hd Ld 3

A pharmacokinetic curve showing plasma concentrations (pg/ml) of Estradiol and Estrone over 24 hours post-dosing. Estrone levels increase rapidly, peak around 4 hours, and then decline, while Estradiol levels remain relatively low and stable throughout the 24-hour period.*

FDA Label Image

Activella Amneal Mfr Hd Ld 4

A line graph depicting the concentration of a substance (in ng/ml) over time (in hours) up to 24 hours. The graph shows a rapid increase in concentration shortly after time zero, peaking before 2 hours, followed by a gradual decline over the remaining hours.*

FDA Label Image

Activella Amneal Mfr Hd Ld 5

A line graph comparing the number of moderate to severe hot flashes per week over 12 weeks among three groups: placebo, 1 mg estradiol, and Activella 1 mg/0.5 mg. The graph shows a decline in hot flashes for both treatment groups, with the Activella group having the greatest reduction.*

FDA Label Image

Activella Amneal Mfr Hd Ld 6

A line graph showing the number of moderate to severe hot flushes over 12 weeks comparing Activella 0.5 mg/0.1 mg tablets and placebo. The vertical axis represents the number of hot flushes, and the horizontal axis represents weeks from 0 to 12. The Activella treatment group shows a decreasing trend in hot flushes over time, whereas the placebo group shows a more gradual decline.*

FDA Label Image

Activella Amneal Mfr Hd Ld 7

A line graph comparing the dissolution profiles of two formulations labeled 1 mg and Activella over 12 capsule cycles. The vertical axis represents percent dissolved (%), and both lines show increasing dissolution over time, with the Activella formulation consistently showing higher dissolution percentages.*

FDA Label Image

Activella Amneal Mfr Hd Ld 8

A line graph showing the percentage of women with no bleeding or spotting across six treatment cycles for Activella 0.5 mg/0.1 mg tablets compared to placebo. The x-axis represents treatment cycles 1 through 6, and the y-axis shows the percentage of women ranging from 40% to 100%. Two lines depict increasing trends over time, with Activella showing higher percentages than placebo throughout.*

FDA Label Image

Activella Amneal Mfr Hd Ld 9

A line chart comparing percentage change over 28-day lunar months for different groups taking Activella 1 mg/0.5 mg in the US and EU, Estradiol 0.5 mg in the US, and placebo in both regions. The x-axis represents lunar months while the y-axis shows percentage change, with distinct markers and error bars for each group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.